Heartstream Launches as an Independent Entity
In a groundbreaking move aimed at enhancing emergency medical services, Heartstream has officially launched as an independent company under the umbrella of Emergency Care Holdings (ECH). This transition marks a significant milestone for ECH, established by Bridgefield Capital to consolidate and grow leading firms in the medical emergency product sector. The formation of Heartstream is set to foster advancements in technologies designed to save lives, particularly for those suffering from cardiac emergencies.
Heartstream emerges following the complete acquisition of the emergency care division of Royal Philips, a major step that allows the company to continue its long-standing mission of improving survival rates during cardiac arrest. Ryan Landon, CEO of Heartstream, emphasized their commitment to elevating survival rates, improving clinical outcomes, and reducing the financial burdens on healthcare systems. “At Heartstream, our mission is to significantly increase survival rates for cardiac arrest, improve clinical outcomes in emergency care, reduce costs for health systems, and lessen the burden on medical staff,” stated Landon.
History and Legacy
Heartstream has deep roots in the field of cardiac care, boasting a history spanning over a century. The company has evolved from its early innovations in heart monitoring to being a leader in automatic external defibrillator (AED) technology. Their portfolio includes groundbreaking technologies developed by various companies, such as Hewlett-Packard and Agilent Technologies.
Throughout its existence, Heartstream has been at the forefront of pioneering innovations, such as the first 12-lead ECG algorithm and the first biphasic defibrillation waveform, which is now an industry standard. Additionally, they were the first to receive FDA approval for a defibrillator sold over the counter, thereby expanding access to AEDs where sudden cardiac arrests occur most frequently.
Focus on Enhancing Emergency Care
As an independent company, Heartstream continues to manufacture and market established emergency care solutions, including HeartStart AEDs and various patient monitoring systems. The firm operates under a multi-year licensing agreement with Philips, ensuring a seamless transition while continuing to offer familiar products to customers.
Sudden cardiac arrest remains a pressing public health challenge, with approximately 72% of incidents occurring outside hospital settings. The American Heart Association notes that survival rates from these incidents fall below 10%, and shockingly, less than 1% of households possess a defibrillator. Against this backdrop, Heartstream's operational focus and strategic investments aim to improve access to AEDs in both public spaces and private homes.
Heartstream is dedicated to enhancing emergency care through a wider global presence, improved supply chain resilience, modernized digital and connected care solutions, and strengthened partnerships with strategic distributors. Furthermore, the company plans to enhance customer-oriented innovations and offers expanded support, services, and clinical training to responders and healthcare providers.
A Commitment to Community
Landon expressed optimism about the future of Heartstream within ECH, asserting that this partnership provides the necessary focus and capital to fortify operations and continue its critical mission. “At the heart of our work is a deep respect for those who rely on our solutions—patients, caregivers, first responders, and ordinary citizens ready to help when lives are at stake,” added Landon.
Heartstream's commitment to patient-centered design ensures that their products meet the diverse needs of healthcare providers and the public, promoting accessible and reliable emergency care—exactly where it is needed most.
As Heartstream embarks on this exciting new chapter, the company remains poised to lead the way in emergency medical services, bridging the gap between advanced technology and real-world application in the quest to save lives.
For more information, visit
Heartstream's website.